Teva Pharmaceuticals USA Inc. is taking the Biden administration to court over its drug price negotiation program, days ...

Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $28.00.

While reporting financial results for the fourth quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) initiated its ...

Teva Pharmaceutical Industries (NYSE:TEVA), a global leader in generic and specialty medicines with a market capitalization of $24.6 billion, has been navigating a complex landscape of legal ...

Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

Below is Validea's guru fundamental report for TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) (TEVA). Of the 22 guru strategies we follow, TEVA rates highest using our Twin Momentum Investor model based ...

In this article, we are going to take a look at where Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) stands against other biggest gainers of last week. Investors gobbled up shares of ...

In this article, we are going to take a look at where Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) stands against the other stocks. The stock market finished the first trading day of the year ...

About Teva:Teva Pharmaceutical Industries Ltd. (NYSE and ... of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...

At HLTH 2022 in Las Vegas, Editor in Chief Jonah Comstock caught up with Manny Montalvo, SVP, head of digital health and innovation at Teva Pharmaceuticals, to talk about Teva's show news ...

NYSE:TEVA opened at $22.42 on Thursday. Teva Pharmaceutical Industries Limited has a 52 week low of $10.34 and a 52 week high of $22.50. The company has a fifty day simple moving average of $17.97 ...